Bilaketaren emaitzak - Axel Finckh

Findu emaitzak
  1. 1
    Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis

    Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis nork Axel Finckh

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    The impact of obesity on the development and progression of rheumatoid arthritis

    The impact of obesity on the development and progression of rheumatoid arthritis nork Axel Finckh, Carl Turesson

    Argitaratua 2014
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

    Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review nork Andrea Rubbert‐Roth, Axel Finckh

    Argitaratua 2009
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study

    The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study nork Axel Finckh, Silvia Dehler, Cem Gabay

    Argitaratua 2008
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment

    Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment nork Axel Finckh, Hyon K. Choi, Frederick Wolfe

    Argitaratua 2006
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study

    The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study nork Diego Kyburz, Cem Gabay, BA Michel, Axel Finckh

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry

    Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry nork Cem Gabay, Myriam Riek, Almut Scherer, Axel Finckh

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Cigarette smoking and radiographic progression in rheumatoid arthritis

    Cigarette smoking and radiographic progression in rheumatoid arthritis nork Axel Finckh, Silvia Dehler, Karen H. Costenbader, Cem Gabay

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis

    Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network... nork Felicity Buckley, Axel Finckh, T. Huizinga, F. Dejonckheere, Jeroen P. Jansen

    Argitaratua 2015
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis

    Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis nork Kim Lauper, Delphine S. Courvoisier, Paola Chevallier, Axel Finckh, Cem Gabay

    Argitaratua 2018
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study

    Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study nork Burkhard Möller, Almut Scherer, Frauke Förger, Peter M. Villiger, Axel Finckh

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    The role of female hormonal factors in the development of rheumatoid arthritis

    The role of female hormonal factors in the development of rheumatoid arthritis nork D. Alpizar-Rodriguez, Nicola Pluchino, G. Canny, Cem Gabay, Axel Finckh

    Argitaratua 2016
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease

    Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease nork Saskia Ditisheim, Nicolas Fournier, Pascal Juillerat, Valérie Pittet, Pierre Michetti, Cem Gabay, Axel Finckh

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort

    Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort nork R Mueller, T. Kaegi, Axel Finckh, Sarah R. Haile, Hendrik Schulze‐Koops, J. von Kempis

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis

    Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis nork Sophie Martin Du Pan, Silvia Dehler, Adrian Ciurea, Hans‐Rudolf Ziswiler, Cem Gabay, Axel Finckh

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Do synovial leptin levels correlate with pain in end stage arthritis?

    Do synovial leptin levels correlate with pain in end stage arthritis? nork Anne Lübbeke, Axel Finckh, Gábor J. Puskás, Domizio Suvà, Alexandre Lädermann, Sylvette Bas, Daniel Fritschy, Cem Gabay, Pierre Hoffmeyer

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

    Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an a... nork Axel Finckh, Adrian Ciurea, Laure Brulhart, Burkhard Möller, Ulrich A. Walker, D. Courvoisier, Diego Kyburz, Jean Dudler, Cem Gabay

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women

    Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women nork Axel Finckh, Glinda S. Cooper, Lori B. Chibnik, Karen H. Costenbader, Julie Watts, Helen Pankey, Patricia A. Fraser, Elizabeth W. Karlson

    Argitaratua 2006
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    <i>Prevotella copri</i> in individuals at risk for rheumatoid arthritis

    <i>Prevotella copri</i> in individuals at risk for rheumatoid arthritis nork D. Alpizar-Rodriguez, Till Robin Lesker, Achim Gronow, Benoît Gilbert, Elena Raemy, Céline Lamacchia, Cem Gabay, Axel Finckh, Till Strowig

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

    Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis nork Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia, Laura Martinez Prat, Michael Mähler, Chelsea Bentow, Axel Finckh, Cem Gabay, Michael J. Nissen

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: